When COVID-19 patients have an acute ischemic stroke (AIS), it can have an especially devastating effect.

Back in April, Attebery announced his resignation from the ACC and MedAxiom.

An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.

The mortality rate was 17% for patients undergoing SAVR following a failed TAVR. 

Treating critically ill COVID-19 patients with a combination of lopinavir (LPV) and ritonavir (RTV) is associated with a significant risk of bradycardia, according to new research out of France.

Stress cardiomyopathy—often referred to as broken heart syndrome—was up significantly in March and April 2020.

Hospitals throughout India have started using humanoid robots to assist with the treatment of COVID-19 patients—and it’s making a big impact.  

Interventional mishaps led to more significant patient harm, but diagnostic and organizational miscues must be accounted for as well, Dutch researches explained in the European Journal of Radiology.